arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Hims & Hers Health, Inc.

HIMS
$28.39 ▼ -2.01 (-6.61%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
31 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

Hims & Hers Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $6.6B
Dividend Yield
Revenue Growth 38.2%
Op. Margin -12.9%
ROIC -27.9%
FCF / Share $-0.16
Trailing P/E
Price / Book 20.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$753.21M
↑ +38.2%
Net Income Profit after all expenses
$-92.11M
— 0.0%
Operating Margin Operating profit as % of sales
-12.9%
— -0.2% 41th
FCF / Share Free cash flow per share
$-0.16
↓ -139.6%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
54
Returns
89
Cash Quality
89

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 31 quarters